Califia Bio (United States)

Recent papers from Califia Bio (United States)

1. Pharmacokinetic profiles of sertraline in pregnancy as a predictor of postpartum depressive symptomsBritish Journal of Clinical Pharmacology · 2025
2. Prediction of lacosamide concentrations to support dose optimization during pregnancyEpilepsia · 2024
3. A multi-scale semi-mechanistic CK/PD model for CAR T-cell therapyFrontiers in Systems Biology · 2024
4. Safety, efficacy, pharmacokinetics, and pharmacodynamics of the illudofulvene drug CAP-0121.Journal of Clinical Oncology · 2024
5. Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myelomaBlood Cancer Journal · 2021
6. The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapyNanomedicine Nanotechnology Biology and Medicine · 2015
7. Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3Journal of Medicinal Chemistry · 2013
8. The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive DisordersJournal of Neuroscience · 2013